Characteristics affecting health-related quality of life (HRQOL) in Japanese patients with reflux oesophagitis and the effect of lansoprazole on HRQOL

Journal of Medical Economics

Volumn 12, Issue 3, 2009, Pages 182-191

  Hongo, Michio ^a   Kinoshita, Yoshikazu ^b   Miwa, Hiroto ^c   Ashida, Kiyoshi ^d  

^a TOHOKU UNIVERSITY HOSPITAL   (Japan)

^b SHIMANE UNIVERSITY   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

^d SAISEIKAI NAKATSU HOSPITAL   (Japan)

Author keywords

Lansoprazole; Proton pump inhibitor; Quality of life; Reflux oesophagitis

Indexed keywords

LANSOPRAZOLE;

ADULT; AGE; AGED; ARTICLE; CLINICAL TRIAL; CONSTIPATION; DIARRHEA; DRUG EFFICACY; FEMALE; GENDER; HEALTH SURVEY; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PALLIATIVE THERAPY; POST HOC ANALYSIS; QUALITY OF LIFE; REFLUX ESOPHAGITIS; SHORT FORM 8;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGE FACTORS; AGED; ANTI-ULCER AGENTS; ESOPHAGITIS, PEPTIC; FEMALE; HEALTH SURVEYS; HUMANS; JAPAN; MALE; MIDDLE AGED; PRODUCT SURVEILLANCE, POSTMARKETING; QUALITY OF LIFE; SEX FACTORS; TREATMENT OUTCOME;

EID: 75149147327     PISSN: 13696998     EISSN: None     Source Type: Journal    
DOI: 10.3111/13696990903227739     Document Type: Article

References (21)

1. Dent J, El-Serag HB, Wallander MA, et al. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005;54:710-717.
2. Wong BC, Kinoshita Y. Systematic review on epidemiology of gastroesophageal reflux disease in Asia. Clin Gastroenterol Hepatol 2006;4:398-407.
3. El-Serag HB. Time trends of gastroesophageal reflux disease: a systematic review. Clin Gastroenterol Hepatol 2007;5:17-26.
4. Robinson M, Fitzgerald S, Hegedus R, et al. Onset of symptom relief with rabeprazole: a community-based, open-label assessment of patients with erosive oesophagitis. Aliment Pharmacol Ther 2002;16:445-454.
5. Kulig M, Leodolter A, Vieth M, et al. Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease - an analysis based on the ProGERD initiative. Aliment Pharmacol Ther 2003;18:767-776.
6. Hongo M, Kinoshita Y, Miwa H, et al. The demographic characteristics and health-related quality of life in a large cohort of reflux esophagitis patients in Japan with reference to the effect of lansoprazole: the REQUEST study. J Gastroenterol 2008;43:920-927.
7. Fukuhara S, Suzukamo Y. Manual of the SF 8 Japanese version. Kyoto, Japan: Institute for Health outcomes & Process Evaluation Research, 2004 [in Japanese].
8. Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999;45:172-180.
9. Hongo M. Minimal changes in reflux esophagitis: red ones and white ones. J Gastroenterol 2006;41:95-99.
10. Ministry of Health, Labor and Welfare. Good Post-marketing Study Practice. Kanpou Gougai 2004;280:2-5 [in Japanese].
11. Stanghellini V, Armstrong D, Monnikes H, et al. Systematic review: do we need a new gastro-oesophageal reflux disease questionnaire? Aliment Pharmacol Ther 2004;19:463-479.
12. Hongo M, Miwa H, Ashida K, et al. The development of a new questionnaire of health-related quality of life for reflux esophagitis. Progress in Medicine 2008;28:2219-2224 [in Japanese].
13. Klinkenberg-Knol EC, Jansen JM, Festen HP, et al. Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis. Lancet 1987;1:349-351.
14. Feldman M, Harford WV, Fisher RS, et al. Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Am J Gastroenterol 1993;88:1212-1217.
15. Lydick E, Epstein RS. Interpretation of quality of life changes. Qual Life Res 1993;2:221-226.
16. Cohen J. Statistical Power Analysis for the Behavioural Sciences. Hillsdale, NJ: Lawrence Erlbaum Associates, 1988.
17. Kimura T, Tsuda Y, Uchida S, et al. Association of perceived stress and stiff neck/shoulder with health status: multiple regression models by gender. Hiroshima J Med Sci 2006;55:101-107.
18. Fujii T, Ogino S, Arimoto H, et al. Quality of life in patients with Japanese cedar pollinosis: using the SF 8 health status questionnaire (Japanese version) Arerugi 2006;55:1288-1294 [in Japanese with English abstract].
19. Ogawa H, Itokazu M, Ito Y, et al. Quality of life evaluated by Short Form-8 in patients with rheumatoid arthritis who were receiving infusion of infliximab. Mod Rheumatol 2009;19:27-32.
20. Endo M, Sekiguchi T, Nakamura T, et al. Efficacy of AG-1749 for reflux esophagitis resistant to H2-receptor antagonist. Rinsho Seijinbyo 1999;29:805-817 [in Japanese].
21. Castell DO, Richter JE, Robinson M, et al. Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. Am J Gastroenterol 1996;91:1749-1757.